On Friday, the FTC announced that was entering a consent decree with 1Health.io Inc., which also does business as Vitagene, Inc. This is the fourth health-related FTC enforcement action announced this year (see here and here).
In addition, it comes on the heels of Virginia, Montana, and, as recently as last week, Texas joining California, Utah, and Arizona in adopting legislation specifically regulating the privacy practices of direct-to-consumer genetic testing companies. The recently adopted Montana law has a broader scope and narrower exceptions that raise questions about whether it will impede research, whereas the Texas law adopted last week is more similar to the other state models.